About Medality Medical
Medality Medical Inc. (Formerly Andrew Technologies LLC) is a privately funded (including an NIH grant) innovative medical technology company focused on reversing type 2 diabetes and associated obesity. The company’s patented and proprietary Targeted Cell Separation and Extraction technology (TC-SET™) was developed by the founder Mark S. Andrew, MD. This technology is FDA-cleared for the removal of subcutaneous fat and has been safely and effectively used on humans since 2013 under the brand name HydraSolve® with outstanding clinical outcomes. In June 2017, the Company made the strategic decision to exclusively focus on excess mesenteric visceral fat extraction due to the tremendous unmet needs associated with type 2 diabetes.